[The new mucosal adjuvant Cry1Ac increase the capacity of mononuclear cells to stop bacterial growth]

MeSH terms

• Amikacin / pharmacology
• Anti-Bacterial Agents / pharmacology
• Bacillus thuringiensis Toxins
• Bacterial Proteins / pharmacology*
• Bacterial Toxins / pharmacology*
• Cells, Cultured / drug effects
• Cells, Cultured / immunology
• Concanavalin A / pharmacology
• Drug Evaluation, Preclinical
• Endotoxins / pharmacology*
• Hemolysin Proteins / pharmacology*
• Humans
• Leukocytes, Mononuclear / drug effects*
• Leukocytes, Mononuclear / immunology
• Microbial Viability / drug effects
• Microbial Viability / immunology*
• Proteus mirabilis / drug effects
• Proteus mirabilis / growth & development
• Pseudomonas aeruginosa / drug effects
• Pseudomonas aeruginosa / growth & development
• Recombinant Proteins / pharmacology
• Salmonella / drug effects
• Salmonella / growth & development
• Staphylococcus aureus / drug effects
• Staphylococcus aureus / growth & development